HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

E H Oldfield Selected Research

Tf-CRM107

1/2000Vascular protection by chloroquine during brain tumor therapy with Tf-CRM107.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


E H Oldfield Research Topics

Disease

12Neoplasms (Cancer)
03/2006 - 01/2000
4Cushing Syndrome
12/2006 - 01/2000
4Pituitary Neoplasms (Pituitary Adenoma)
09/2001 - 03/2000
3Infarction (Infarctions)
04/2001 - 04/2000
3Reperfusion Injury
04/2001 - 04/2000
2Stroke (Strokes)
04/2001 - 04/2000
2Ischemia
04/2001 - 04/2000
1Disease Progression
01/2007
1Gaucher Disease (Gaucher's Disease)
01/2007
1Pituitary ACTH Hypersecretion
12/2006
1Astrocytoma (Pilocytic Astrocytoma)
03/2006
1Peripheral Nerve Injuries
12/2001
1Crush Injuries
12/2001
1Neurofibromatosis 2 (Neurofibromatosis Type II)
12/2001
1Glioblastoma (Glioblastoma Multiforme)
12/2001
1Meningioma (Meningiomas)
12/2001
1Rhabdomyosarcoma
10/2001
1Ewing Sarcoma (Sarcoma, Ewing)
10/2001
1Neuroblastoma
10/2001
1Lymphoma (Lymphomas)
10/2001
1Primitive Neuroectodermal Tumors (PNET)
10/2001
1Medulloblastoma
10/2001
1Hyperthyroidism
08/2001
1Residual Neoplasm
08/2001
1Intracranial Embolism
04/2001
1Hypoxia (Hypoxemia)
03/2001
1Prolactinoma (Prolactinomas)
11/2000
1Ischemic Stroke
07/2000
1Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
04/2000
1Acromegaly
03/2000
1Carney Complex
03/2000
1Gigantism
03/2000
1Paraplegia (Spastic Paraplegia)
02/2000
1Radiculopathy (Radiculopathy, Cervical)
02/2000
1Hemangioma (Angioma)
02/2000
1Spontaneous Fractures (Pathological Fracture)
02/2000
1Thrombosis (Thrombus)
01/2000
1Hemorrhage
01/2000
1Glioma (Gliomas)
01/2000
1Brain Neoplasms (Brain Tumor)
01/2000
1Intracranial Vasospasm
01/2000
1Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
01/2000
1Spasm (Spasms)
01/2000

Drug/Important Bio-Agent (IBA)

4Adrenocorticotropic Hormone (ACTH)FDA Link
12/2006 - 01/2000
3EnzymesIBA
01/2007 - 01/2000
3DNA (Deoxyribonucleic Acid)IBA
12/2001 - 12/2000
2Thyroid HormonesIBA
11/2001 - 09/2001
2Nitric Oxide (Nitrogen Monoxide)FDA Link
04/2001 - 01/2000
2Free RadicalsIBA
04/2001 - 07/2000
2Oxygen (Dioxygen)IBA
04/2001 - 07/2000
2Reactive Oxygen Species (Oxygen Radicals)IBA
04/2001 - 04/2000
2Growth Hormone (Somatotropin)IBA
11/2000 - 03/2000
1Glucosylceramidase (Glucocerebrosidase)IBA
01/2007
1Tumor Biomarkers (Tumor Markers)IBA
03/2006
1Proteins (Proteins, Gene)FDA Link
03/2006
1AlbuminsIBA
12/2001
1Thyroid Hormone Receptors (Thyroid Hormone Receptor)IBA
09/2001
1Hormones (Hormone)IBA
09/2001
1Thyrotropin (Thyroid-Stimulating Hormone)FDA Link
08/2001
1Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
08/2001
1lanreotide (Somatuline)FDA Link
08/2001
1Octreotide (Sandostatin)FDA LinkGeneric
08/2001
1Tissue Plasminogen Activator (Alteplase)FDA Link
04/2001
12,3-dihydroxybenzoic acidIBA
04/2001
1Proline (L-Proline)FDA Link
04/2001
1AntibodiesIBA
03/2001
1RNA (Ribonucleic Acid)IBA
03/2001
1Carbonic Anhydrases (Carbonic Anhydrase)IBA
03/2001
1GastrinsIBA
12/2000
1ProlactinIBA
11/2000
11,1-diethyl-2-hydroxy-2-nitrosohydrazineIBA
07/2000
1nitroxylIBA
04/2000
1Fibrinolytic Agents (Antithrombotic Agents)IBA
04/2000
1tempolIBA
04/2000
1Biological ProductsIBA
03/2000
1GadoliniumIBA
02/2000
1Ethanol (Ethyl Alcohol)IBA
02/2000
1Indicators and Reagents (Reagents)IBA
01/2000
1Tf-CRM107IBA
01/2000
1Chloroquine (Aralen)FDA LinkGeneric
01/2000
1Corticotropin-Releasing HormoneIBA
01/2000
1Arginine (L-Arginine)FDA Link
01/2000
1Hemoglobins (Hemoglobin)IBA
01/2000
1Nitric Oxide Synthase (NO Synthase)IBA
01/2000

Therapy/Procedure

4Therapeutics
12/2001 - 01/2000
1Immunotherapy
12/2001
1Contraindications
06/2000
1Sutures (Suture)
04/2000
1Intralesional Injections
02/2000
1Aftercare (After-Treatment)
02/2000
1Intravenous Infusions
01/2000